Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Non-Current Deffered Revenue (2022)

Historic Non-Current Deffered Revenue for Roivant Sciences (ROIV) over the last 1 years, with Q3 2022 value amounting to $11.9 million.

  • Roivant Sciences' Non-Current Deffered Revenue changed N/A to $11.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $11.9 million, marking a year-over-year change of. This contributed to the annual value of $13.7 million for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q3 2022, Roivant Sciences' Non-Current Deffered Revenue is $11.9 million.
  • Roivant Sciences' 5-year Non-Current Deffered Revenue high stood at $13.7 million for Q1 2022, and its period low was $11.9 million during Q3 2022.